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This special issue of the Journal of Drug Targeting marks the past, and the continuing 
contribution of Ruth Duncan to the field of drug delivery, more specifically the branch 
termed "Polymer Therapeutics". The three of us have witnessed, for more than 20 
years, Ruth’s never-ending enthusiasm and persistence in many different 
interdisciplinary arenas under this banner, and the immense scientific contribution to the 
field of drug delivery this vision (and tenacity) has generated. It has been a pleasure for 
us to edit this special issue, which pays tribute to her outstanding achievements within 
the context of the Journal of Drug Targeting- Lifetime Achievement Award for 2017. 
With these few words, we wish to applaud Ruth’s contribution, and briefly give some 
background to the seminal, interesting papers relating to polymer therapeutics and drug 
delivery contained herein. We would also like to send special thanks to all who have 
contributed, and to acknowledge that many of the authors are Ruth’s collaborators (of 
different generations) and friends. To those new to the field of polymer therapeutics (a 
discipline pioneered by Ruth and her co-workers), you will read of new and exciting 
topics that illustrate the importance of research at the interface of polymer science, cell 
biology, computer modelling, metabolomics and drug delivery. These papers represent 
“drug targeting research” at its best, and illustrate the opportunities, ongoing debates 
and challenges in the field.  
Contributors to this special issue include collaborators from the early work between 
Ruth, whilst at Keele University and Blanka Rihova from Prague (PK1 standing for 
Prague and Keele 1, denoting the collaboration) and Paolo Ferruti from the University 
of Milan. Hiroshi Maeda, who first described the enhanced permeability and retention 
(EPR) effect, a key feature of the patho-physiological rationale for the development of 
polymer therapeutics also contributed a review featured in this special issue. Simon 
Richardson and Ronit Satchi-Fainaro representing Ruth’s lab students at the Center 
of Polymer Therapeutics in London (1994-2001), Philipp Seib, María J. Vicent, 
Francesca Greco, Lorella Izzo and Elaine Ferguson represent different generations 
of Ruth's period at Cardiff University (2001-2008) along with Peter Griffiths and Alison 
Paul, who were collaborators from Cardiff University and also have contributions herein. 
Gianfranco Pasut, who did his PhD with Ruth’s long term collaborator and friend, 
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Francesco Veronese from Padova University, as well as Steve Brocchini, Iola Duarte, 
Silvia Muro and Helena Florindo representing four of the many PIs mentored and 
supported by Ruth during the journey towards their current well-established research 
positions. Many of us meet regularly every two years at the International Symposium on 
Polymer Therapeutics thanks to Ruth, who initiated and established this conference 
series. 
Personal Reflections 
Although we (Ronit and Simon) first came to know Ruth after she returned from 
industry, whilst tenured at the School of Pharmacy, University of London, or after 
moving to Cardiff University (María), we realized at a very early stage the special view 
Ruth had of the Polymer Therapeutics field, a term she coined whilst establishing one of 
the most successful polymeric nanomedicine laboratories in the world. Her academic 
background originating in cell biology and gravitated towards polymer chemistry and 
drug delivery, her deep understanding at the bench, and her ability to develop these 
ideas to a point where they are ready for trial at the bedside, complemented each very 
well over the last decades. This, along with her involvement with the regulatory 
agencies made her a researcher always seeking the patients’ benefit. 
Starting from the studies of Ringsdorf and also De Duve, Ruth managed not only to 
transfer the first polymer-drug conjugates (N-(2-hydroxypropylmethacrylamide) (HPMA) 
copolymer-doxorubicin conjugates) into the clinic, collaborating with the Institute of 
Macromolecular Chemistry in Prague (Jindrich and Pavla Kopecek, Karel Ulbrich and 
Blanka Rihova—see papers in this volume), but also to establish new, innovative and 
very diverse concepts in the field. These concepts opened up many strategies and 
opportunities to tackle some of the field’s major challenges, including topics like gene 
therapy and robust nanomedicines' physico-chemical characterization, suitable for 
transfer to the clinic. Drawing upon Ruth’s roots in cell biology, a very interesting 
avenue of research opened in collaboration with Paolo Ferruti in Milan using linear 
polyamidoamine polymers. These were used to burst specific intracellular membranes 
and were recognized by Ruth as a means to facilitate the intracellular delivery of 
proteins and nucleic acids. This research was initiated at Keele and continued in both 
London and Cardiff. Understanding the integral mechanisms of polyamidoamine activity 
also highlighted another underlying theme central to Ruth’s work, correlating structure 
with functional activity, a theme which can been seen throughout her work with 
Francesco Veronese (PEG-Doxorubicin) and Peter Griffiths (see papers in this 
volume) using Small Angle Neutron Scattering (SANS) to define polymer solution 
properties. 
In addition to the well-established and respected scientists already mentioned, special 
attention is owed to some of the people who joined Ruth and supported her from the 
beginning. Most notable are Professor Helmut Ringsdorf and Professor Tom Connors, 
both visiting Professors in Ruth’s Lab (CPT) and frequent visitors and advisors during 
Ronit’s and Simon’s time as Ruth’s PhD students. Unfortunately, Maria did not have the 
chance to meet Tom Connors but still benefited from the endless enthusiasm and deep 
knowledge of Helmut who taught us all that life and science are way too complicated to 
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be taken seriously. Further, we would like to highlight Ruth’s continuous support for 
young people, not only us as part of her own CPT family, but also talented, enthusiastic 
young scientists now well-established in their independent careers. 
Her strong support for researchers in second and third world countries, such as South 
Africa and Malaysia, in order to promote good science as well as present their clinical 
needs to the rest of the world merits great commendation. Ruth’s enthusiasm and 
willingness to promote not only good science but a patient-centric approach to medicine 
has been emphasized in her thoughtful, critical, and determined approach to teaching 
and mentoring interdisciplinary scientists and scientific ambassadors worldwide. 
We left Ruth’s lab to establish our own independent careers, now in Israel, USA, UK 
and Spain with Ruth’s unfailing support throughout, promoting our research in her 
invited and plenary lectures across the globe. Also, several generations of our PhD 
students and postdocs at Tel Aviv, Greenwich or Valencia have benefited from her 
continued advice and mentorship during her Visiting Professorships. 
In conclusion, we cannot think of a more worthy recipient of the Journal of Drug 
Targeting’s Lifetime Achievement Award. Over the last four decades, Prof. Ruth Duncan 
has, more than any other, continued to inspire and promote multidisciplinary research in 
drug delivery at the interface of polymer chemistry, biology, industry and the clinic. Her 
approach, therapeutics and pioneering strategies are well known worldwide. They also 
continue to be the inspiration for a large number of researchers with very different 
backgrounds, and focus on the same final goal of trying to benefit and fulfill patient 
needs. 
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